Celltrion
068270.KS
#755
Rank
$32.52 B
Marketcap
$148.68
Share price
1.40%
Change (1 day)
27.17%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): $1.89

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $1.89. In 2024 the company made an earnings per share (EPS) of $1.34 a decrease over its 2023 EPS that were of $2.66.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$1.8941.11%
2024$1.34-49.57%
2023$2.66-2.08%
2022$2.72-11.72%
2021$3.082.03%
2020$3.0282.8%
2019$1.6518.31%
2018$1.40-36.33%
2017$2.19161.25%
2016$0.842.86%
2015$0.8217.84%
2014$0.695.87%
2013$0.65-70.85%
2012$2.24134.09%
2011$0.9643.59%
2010$0.6774.49%
2009$0.38317.8%
2008$0.09150-71.7%
2007$0.32